Hiroshi Kimura
- Oncology top 0.2%
- Viral-associated cancers and disorders 157
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 64
- Immunology top 0.5%
- Immune Cell Function and Interaction 55
- Infectious Diseases top 0.5%
- Parvovirus B19 Infection Studies 55
- Epidemiology top 0.5%
- Cytomegalovirus and herpesvirus research 96
- Herpesvirus Infections and Treatments 70
-
- Eosinophilic Disorders and Syndromes 27
-
- Autoimmune and Inflammatory Disorders Research 21
Hiroshi Kimura
455 papers receiving 13.5k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Oncology 5.7k
- Pathology and Forensic Medicine 2.9k
- Immunology 3.2k
- Infectious Diseases 2.6k
- Epidemiology 4.3k
Countries citing papers authored by Hiroshi Kimura
This map shows the geographic impact of Hiroshi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kimura more than expected).
Fields of papers citing papers by Hiroshi Kimura
This network shows the impact of papers produced by Hiroshi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kimura. The network helps show where Hiroshi Kimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Kimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2020 | 53 | |
| 3 | 2017 | 0 | |
| 4 | Feasibility and efficacy of definitive radiotherapy with 66 GY and concurrent carboplatin-paclitaxel chemotherapy for stage III non-small cell lung cancer. | 2017 | 1 |
| 5 | 2014 | 27 | |
| 6 | 2014 | 50 | |
| 7 | 2014 | 79 | |
| 8 | 2013 | 17 | |
| 9 | 2012 | 77 | |
| 10 | 2009 | 1 | |
| 11 | 2004 | 70 | |
| 12 | Suppression of Ground Radar Interference in JERS-1 SAR Data | 2004 | 6 |
| 13 | 2003 | 166 | |
| 14 | 2003 | 1 | |
| 15 | Clinical and virologic characteristic of chronic active Epstein-Barr virus infection | 2001 | 6 |
| 16 | 1994 | 1 | |
| 17 | 1994 | 0 | |
| 18 | 1992 | 67 | |
| 19 | Survival, development and reproduction of a selected strain of the melon fly, Dacus cucurbitae Coquillett, (Diptera: Tephritidae). | 1990 | 1 |
| 20 | 1974 | 1 |
About Hiroshi Kimura
Hiroshi Kimura is a scholar working on Oncology, Epidemiology and Immunology, having authored 481 papers that have together received 13.8k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (157 papers), Cytomegalovirus and herpesvirus research (96 papers), Herpesvirus Infections and Treatments (70 papers), Lymphoma Diagnosis and Treatment (64 papers), Parvovirus B19 Infection Studies (55 papers), Immune Cell Function and Interaction (55 papers), Eosinophilic Disorders and Syndromes (27 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). The work is most often cited by research in Oncology (5.7k citations), Pathology and Forensic Medicine (2.9k citations) and Immunology (3.2k citations). Hiroshi Kimura has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tsuneo Morishima, Yoshinori Ito, Kiyotaka Kuzushima, Yukihiro Nishiyama, Seiji Kojima, Yo Hoshino, Jun‐ichi Kawada, Toshihiro Maeda, Hisao Tago and Takayuki Murata. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Virology, Blood, Journal of Medical Virology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.